Re: Marzan has "new minions"
While nothing can be ruled out, I believe they have sufficient funds to reach the SNO conference where I expect sufficient information on the Phase 3 Trial that the price will be up substantially, that would be the time to issue more shares if such action is necessary. On the other hand, with the release of the data they may have one or more offers to partner, or purchase DCVax-L or perhaps even the entire company, or a percentage of it.
I believe the data will be worthy of approval which should certainly bring a billion dollar market cap in time, if not almost instantly. With approval the only real question is how high the market cap may go, or will the company be bought out.